According to KYORIN Pharmaceutical's latest financial reports the company's current revenue (TTM) is $0.84 B. In 2022 the company made a revenue of $0.81 B a decrease over the years 2021 revenue that were of $0.94 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.84 B | 3.42% |
2022 | $0.81 B | -13.17% |
2021 | $0.94 B | -5.83% |
2020 | $1.00 B | -0.77% |
2019 | $1.00 B | 1.34% |
2018 | $0.99 B | 0.36% |
2017 | $0.99 B | -7.95% |
2016 | $1.07 B | 9.4% |
2015 | $0.98 B | -4.29% |
2014 | $1.02 B | -8.12% |
2013 | $1.12 B | -12.62% |
2012 | $1.28 B | -3.62% |
2011 | $1.33 B | 13.89% |
2010 | $1.16 B | 11.32% |
2009 | $1.04 B |